4//SEC Filing
Cooper Laurence James Neil 4
Accession 0001209191-19-000586
CIK 0001107421other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:15 PM ET
Size
8.0 KB
Accession
0001209191-19-000586
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Tax Payment
Common Stock
2018-12-30$1.66/sh−26,178$43,455→ 1,196,965 total - Tax Payment
Common Stock
2018-12-29$1.66/sh−42,920$71,247→ 1,223,143 total - Tax Payment
Common Stock
2018-12-31$1.87/sh−16,156$30,212→ 1,180,809 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001641506
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 9:15 PM ET
- Size
- 8.0 KB